1. Home
  2. GWAV vs MBIO Comparison

GWAV vs MBIO Comparison

Compare GWAV & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenwave Technology Solutions Inc.

GWAV

Greenwave Technology Solutions Inc.

HOLD

Current Price

$5.22

Market Cap

4.3M

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.99

Market Cap

4.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GWAV
MBIO
Founded
2002
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
4.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GWAV
MBIO
Price
$5.22
$0.99
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
359.2K
72.4K
Earning Date
11-14-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$32,144,792.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.25
$0.89
52 Week High
$59.63
$7.00

Technical Indicators

Market Signals
Indicator
GWAV
MBIO
Relative Strength Index (RSI) 48.49 39.25
Support Level $4.81 $1.07
Resistance Level $6.24 $1.20
Average True Range (ATR) 0.60 0.06
MACD 0.08 0.00
Stochastic Oscillator 47.94 29.63

Price Performance

Historical Comparison
GWAV
MBIO

About GWAV Greenwave Technology Solutions Inc.

Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia, Ohio and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company involves collecting, classifying and processing appliances, construction material, end-of-life vehicles, boats, and industrial machinery and processing those items by crushing, shearing, shredding, separating, and sorting, into smaller pieces and categorize these recycled ferrous, nonferrous, and mixed metal pieces based on density and metal prior to sale.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: